📰 Evant Keller News
Evant Keller News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Evant Keller. Real-time updates on events, politics, business and more.
September 26, 2022
A dental school dean with a history of publishing cancer research papers is up to five retractions.
July 7, 2022
Spexis AG / Key word(s): Research UpdateSpexis' CXCR4 inhibitor balixafortide demonstrates synergistic efficacy in combination with docetaxel in a metastatic prostate cancer preclinical model 07.07.2022 / 07:30 Allschwil, Switzerland, July 7, 2022Spexis' CXCR4 inhibitor balixafortide demonstrates synergistic eff...
October 26, 2021
Around the Corner or Pipe Dream? The new omics-based technology may be taking research labs by storm, but will it have a similar impact in the clinic?